Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.

Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R; Partnership for Rapid Elimination of Trachoma (PRET) study group.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2115. doi: 10.1371/journal.pntd.0002115. Print 2013. Erratum in: PLoS Negl Trop Dis. 2013 Jun;7(6). doi:10.1371/annotation/0bae8b34-5ae7-4044-a071-8d88d520a01b.

2.

Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.

Yohannan J, Munoz B, Mkocha H, Gaydos CA, Bailey R, Lietman TA, Quinn T, West SK.

JAMA Ophthalmol. 2013 Apr;131(4):431-6. doi: 10.1001/jamaophthalmol.2013.2356.

3.

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.

Harding-Esch E, Jofre-Bonet M, Dhanjal JK, Burr S, Edwards T, Holland M, Sillah A, West S, Lietman T, Keenan J, Mabey D, Bailey R.

PLoS Negl Trop Dis. 2015 Apr 22;9(4):e0003670. doi: 10.1371/journal.pntd.0003670. eCollection 2015 Apr.

4.

A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.

West SK, Bailey R, Munoz B, Edwards T, Mkocha H, Gaydos C, Lietman T, Porco T, Mabey D, Quinn TC.

PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2415. doi: 10.1371/journal.pntd.0002415. eCollection 2013.

5.

The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.

Lee JS, Muñoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK.

PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2761. doi: 10.1371/journal.pntd.0002761. eCollection 2014 Apr.

6.

Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.

West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1492-7.

PMID:
17389476
7.

Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.

Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, Holland M, Gaydos C, West S.

Ophthalmic Epidemiol. 2011 Feb;18(1):20-9. doi: 10.3109/09286586.2010.545500.

PMID:
21275593
8.

Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.

Burton MJ, Holland MJ, Makalo P, Aryee EA, Sillah A, Cohuet S, Natividad A, Alexander ND, Mabey DC, Bailey RL.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e835. doi: 10.1371/journal.pntd.0000835.

9.

Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.

Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, Chin S, West SK, Bailey RL, Mabey DC, Keenan JD, Porco TC, Lietman TM, Gaynor BD; PRET Partnership.

PLoS Negl Trop Dis. 2012;6(4):e1586. doi: 10.1371/journal.pntd.0001586. Epub 2012 Apr 24.

10.

Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.

King JD, Teferi T, Cromwell EA, Zerihun M, Ngondi JM, Damte M, Ayalew F, Tadesse Z, Gebre T, Mulualem A, Karie A, Melak B, Adugna M, Gessesse D, Worku A, Endashaw T, Admassu Ayele F, Stoller NE, King MR, Mosher AW, Gebregzabher T, Haileysus G, Odermatt P, Utzinger J, Emerson PM.

PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2732. doi: 10.1371/journal.pntd.0002732. eCollection 2014 Mar.

11.

Mass treatment with azithromycin for trachoma control: participation clusters in households.

Ssemanda EN, Munoz B, Harding-Esch EM, Edwards T, Mkocha H, Bailey RL, Sillah A, Stare D, Mabey DC, West SK; PRET Project Team.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e838. doi: 10.1371/journal.pntd.0000838.

12.

Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania.

Shekhawat N, Mkocha H, Munoz B, Gaydos C, Dize L, Quinn TC, West SK.

Invest Ophthalmol Vis Sci. 2014 Apr 11;55(4):2307-14. doi: 10.1167/iovs.13-12701.

13.

Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.

West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC.

J Infect Dis. 2011 Jul 15;204(2):268-73. doi: 10.1093/infdis/jir257.

14.

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control.

Burr SE, Hart J, Edwards T, Harding-Esch EM, Holland MJ, Mabey DC, Sillah A, Bailey RL.

BMC Public Health. 2014 Nov 18;14:1176. doi: 10.1186/1471-2458-14-1176.

15.

Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.

Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.

Lancet. 2005 Apr 9-15;365(9467):1321-8.

PMID:
15823382
16.

Risk factors for ocular chlamydia after three mass azithromycin distributions.

Ayele B, Gebre T, Moncada J, House JI, Stoller NE, Zhou Z, Porco TC, Gaynor BD, Emerson PM, Schachter J, Keenan JD.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1441. doi: 10.1371/journal.pntd.0001441. Epub 2011 Dec 13.

17.

Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali.

Bamani S, King JD, Dembele M, Coulibaly F, Sankara D, Kamissoko Y, Ting J, Rotondo LA, Emerson PM.

PLoS Negl Trop Dis. 2010 Jul 6;4(7):e734. doi: 10.1371/journal.pntd.0000734.

18.

Mass treatment with single-dose azithromycin for trachoma.

Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.

N Engl J Med. 2004 Nov 4;351(19):1962-71.

19.

Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?

West SK, Moncada J, Munoz B, Mkocha H, Storey P, Hardick J, Gaydos CA, Quinn TC, Schachter J.

J Infect Dis. 2014 Jul 1;210(1):65-71. Epub 2014 Jan 19.

20.

Antibiotics for trachoma.

Evans JR, Solomon AW.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001860. doi: 10.1002/14651858.CD001860.pub3. Review.

PMID:
21412875
Items per page

Supplemental Content

Write to the Help Desk